Infinity Pharmaceuticals Inc. (INFI)

INFI (NASDAQ:Biotechnology) EQUITY
$2.03
pos +0.31
+18.02%
Today's Range: 1.77 - 2.08 | INFI Avg Daily Volume: 612,200
Last Update: 06/22/18 - 12:30 PM EDT
Volume: 1,873,066
YTD Performance: -15.27%
Open: $1.80
Previous Close: $1.72
52 Week Range: $0.93 - $3.75
Oustanding Shares: 56,070,000
Market Cap: 98,683,197
6-Month Chart
TheStreet Ratings Grade for INFI
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.33 2.50 2.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -2.20
Price Earnings Comparisons:
INFI Sector Avg. S&P 500
-2.20 0.00 20.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-32.28% -12.24% -85.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue -67.95 -1.00 -0.67
Net Income 36.07 1.40 0.00
EPS 36.07 1.30 0.00
Earnings for INFI:
EBITDA -0.03B
Revenue 0.01B
Average Earnings Estimates
Qtr (06/18) Qtr (09/18) FY (12/18) FY (12/19)
Average Estimate $-0.20 $-0.20 $-0.75 $-0.72
Number of Analysts 4 4 4 4
High Estimate $-0.19 $-0.18 $-0.71 $-0.59
Low Estimate $-0.21 $-0.22 $-0.78 $-0.88
Prior Year $-0.34 $-0.14 $-0.83 $-0.75
Growth Rate (Year over Year) 41.91% -42.86% 9.34% 4.98%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Until market conditions shift, I won't be making any sizable buys.
Bullish
Oct 12, 2017 | 10:41 AM EDT
Infinity Pharma rating was increased to "outperform" with a $5 price target at Wells Fargo.
Analysts cut valuation estimates after a disappointing drug study. 
Stocks were falling slightly in premarket trading Tuesday as oil continued its six-day descent.
Bullish
May 07, 2015 | 7:05 AM EDT
INFI was initiated with a Buy rating, Deutsche Bank said. $20 price target. Small cap stock to own for long term capital appreciation. ...
Update
May 07, 2014 | 8:26 AM EDT
INFI was upgraded to Buy from Hold, Jefferies said. Commerical competitiveness already priced in and risk/reward is attractive. $13 pri...

Earnings Roundup Real Money Pro($)

Here is my compilation of last night's profit reports.

Off the Charts Real Money Pro($)

When ranges increase and the market becomes choppy near upper levels, it's cause for caution.

Columnist Conversations

Via the technicals.....we know that we had time/price parameters at the low in August Crude and key weekly sup...
Red Hat (RHT) is trading inside our long term bounce zone @ 149.49-142.82 today. Day 1 of 3 day rule, so I wo...
Today is potentially one of the most exciting days of the year for stock traders. Several Russell indices will...
As Starbucks (SBUX) signals change in consumer preferences away from sugary beverages, we've got a new pick th...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.